Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pearson is a global leader in educational and clinical assessment services, providing a wide array of diagnostic tools used in healthcare, psychology, and education. The company is the publisher of the Kaufman Assessment Battery for Children (K-ABC), a gold-standard clinical instrument used by neuropsychologists and clinicians to evaluate cognitive development and inform treatment planning for neurodevelopmental disorders. Pearson's clinical division focuses on evidence-based assessments that support the diagnosis of conditions such as ADHD, autism, and learning disabilities. Through its digital platforms like Q-interactive, the company integrates traditional psychological testing with modern technology to streamline clinical workflows. Pearson operates globally, serving healthcare providers, academic institutions, and government agencies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KABC.